{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:11:39Z","timestamp":1790518299630,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.1038\/sj.mp.4001144","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T21:08:45Z","timestamp":1031087325000},"page":"617-625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry"],"prefix":"10.1038","volume":"7","author":[{"given":"E J","family":"Nordstrom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F H","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,30]]},"reference":[{"key":"BF4001144_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM198610163151604","volume":"315","author":"DL Pauls","year":"1986","unstructured":"Pauls DL, Leckman JF . The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission N Engl J Med 1986 315: 993\u2013997","journal-title":"N Engl J Med"},{"key":"BF4001144_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00005792-199101000-00002","volume":"70","author":"HS Singer","year":"1991","unstructured":"Singer HS, Walkup JT . Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment Medicine (Baltimore) 1991 70: 15\u201332","journal-title":"Medicine (Baltimore)"},{"key":"BF4001144_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/088307389801300901","volume":"13","author":"MA Garvey","year":"1998","unstructured":"Garvey MA, Giedd J, Swedo SE . PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever J Child Neurol 1998 13: 413\u2013923","journal-title":"J Child Neurol"},{"key":"BF4001144_CR4","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1176\/ajp.149.9.1244","volume":"149","author":"HL Leonard","year":"1992","unstructured":"Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapoport JL . Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children Am J Psychiatry 1992 149: 1244\u20131251","journal-title":"Am J Psychiatry"},{"key":"BF4001144_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/WNL.36.3.378","volume":"36","author":"M Frankel","year":"1986","unstructured":"Frankel M, Cummings JL, Robertson MM, Trimble MR, Hill MA, Benson DF . Obsessions and compulsions in Gilles de la Tourette's syndrome Neurology 1986 36: 378\u2013382","journal-title":"Neurology"},{"key":"BF4001144_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0165-0327(99)00019-1","volume":"56","author":"M Van Ameringen","year":"1999","unstructured":"Van Ameringen M, Mancini C, Oakman JM, Farvolden P . The potential role of haloperidol in the treatment of trichotillomania J Affect Disord 1999 56: 219\u2013226","journal-title":"J Affect Disord"},{"key":"BF4001144_CR7","doi-asserted-by":"crossref","unstructured":"The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders Arch Neurol 1993 50: 1013\u20131016","DOI":"10.1001\/archneur.1993.00540100012008"},{"key":"BF4001144_CR8","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn American Psychiatric Press: Washington, DC 1994 p xxvii 78\u2013105 886"},{"key":"BF4001144_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0272-7358(98)00059-2","volume":"19","author":"DM Sheppard","year":"1999","unstructured":"Sheppard DM, Bradshaw JL, Purcell R, Pantelis C . Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder A common etiology? Clin Psychol Rev 1999 19: 531\u2013552","journal-title":"A common etiology? Clin Psychol Rev"},{"key":"BF4001144_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/mds.870050211","volume":"5","author":"R Kurlan","year":"1990","unstructured":"Kurlan R, Kersun J, Ballantine HT Jr, Caine ED . Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome Mov Disord 1990 5: 152\u2013155","journal-title":"Mov Disord"},{"key":"BF4001144_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1001\/archpsyc.1992.01820090018003","volume":"49","author":"SE Swedo","year":"1992","unstructured":"Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy Arch Gen Psychiatry 1992 49: 690\u2013694","journal-title":"Arch Gen Psychiatry"},{"key":"BF4001144_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/archpsyc.1996.01830070041008","volume":"53","author":"HC Breiter","year":"1996","unstructured":"Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder Arch Gen Psychiatry 1996 53: 595\u2013606","journal-title":"Arch Gen Psychiatry"},{"key":"BF4001144_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.54.1.142","volume":"54","author":"BD Greenberg","year":"2000","unstructured":"Greenberg BD, Ziemann U, Cora-Locatelli G, Harmon A, Murphy DL, Keel JC et al. Altered cortical excitability in obsessive-compulsive disorder Neurology 2000 54: 142\u2013147","journal-title":"Neurology"},{"key":"BF4001144_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1176\/ajp.154.9.1277","volume":"154","author":"U Ziemann","year":"1997","unstructured":"Ziemann U, Paulus W, Rothenberger A . Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation Am J Psychiatry 1997 154: 1277\u20131284","journal-title":"Am J Psychiatry"},{"key":"BF4001144_CR15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","volume":"39","author":"DR Rosenberg","year":"2000","unstructured":"Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ . Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine J Am Acad Child Adolesc Psychiatry 2000 39: 1096\u20131103","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF4001144_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/syn.890090307","volume":"9","author":"PW Sheldon","year":"1991","unstructured":"Sheldon PW, Aghajanian GK . Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons Synapse 1991 9: 208\u2013218","journal-title":"Synapse"},{"key":"BF4001144_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1073\/pnas.95.2.735","volume":"95","author":"RL Jakab","year":"1998","unstructured":"Jakab RL, Goldman-Rakic PS . 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc Natl Acad Sci USA 1998 95: 735\u2013740","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4001144_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","volume":"825","author":"GK Aghajanian","year":"1999","unstructured":"Aghajanian GK, Marek GJ . Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release Brain Res 1999 825: 161\u2013171","journal-title":"Brain Res"},{"key":"BF4001144_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0193-953X(18)30260-0","volume":"15","author":"DJ Cohen","year":"1992","unstructured":"Cohen DJ, Riddle MA, Leckman JF . Pharmacotherapy of Tourette's syndrome and associated disorders Psychiatr Clin North Am 1992 15: 109\u2013129","journal-title":"Psychiatr Clin North Am"},{"key":"BF4001144_CR20","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1523\/JNEUROSCI.19-12-05044.1999","volume":"19","author":"KM Campbell","year":"1999","unstructured":"Campbell KM, de Lecea L, Severynse DM, Caron MG, McGrath MJ, Sparber SB et al. OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons J Neurosci 1999 19: 5044\u20135053","journal-title":"J Neurosci"},{"key":"BF4001144_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/350074a0","volume":"350","author":"FH Burton","year":"1991","unstructured":"Burton FH, Hasel KW, Bloom FE, Sutcliffe JG . Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene Nature 1991 350: 74\u201377","journal-title":"Nature"},{"key":"BF4001144_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/cne.903510304","volume":"351","author":"DE Wright","year":"1995","unstructured":"Wright DE, Seroogy KB, Lundgren KH, Davis BM, Jennes L . Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain J Comp Neurol 1995 351: 357\u2013373","journal-title":"J Comp Neurol"},{"key":"BF4001144_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0006-8993(99)01544-9","volume":"833","author":"KM Campbell","year":"1999","unstructured":"Campbell KM, McGrath MJ, Burton FH . Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion Brain Res 1999 833: 216\u2013224","journal-title":"Brain Res"},{"key":"BF4001144_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00008877-199909000-00001","volume":"10","author":"MJ McGrath","year":"1999","unstructured":"McGrath MJ, Campbell KM, Veldman MB, Burton FH . Anxiety in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior Behav Pharmacol 1999 10: 435\u2013443","journal-title":"Behav Pharmacol"},{"key":"BF4001144_CR25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1037\/0735-7044.113.6.1249","volume":"113","author":"MJ McGrath","year":"1999","unstructured":"McGrath MJ, Campbell KM, Burton FH . The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior Behav Neurosci 1999 113: 1249\u20131256","journal-title":"Behav Neurosci"},{"key":"BF4001144_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","volume":"9","author":"GE Alexander","year":"1986","unstructured":"Alexander GE, DeLong MR, Strick PL . Parallel organization of functionally segregated circuits linking basal ganglia and cortex Annu Rev Neurosci 1986 9: 357\u2013381","journal-title":"Annu Rev Neurosci"},{"key":"BF4001144_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1001\/archpsyc.1978.01770260123015","volume":"35","author":"DJ Cohen","year":"1978","unstructured":"Cohen DJ, Shaywitz BA, Caparulo B, Young JG, Bowers MB Jr . Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration Arch Gen Psychiatry 1978 35: 245\u2013250","journal-title":"Arch Gen Psychiatry"},{"key":"BF4001144_CR28","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1176\/ajp.145.3.388-a","volume":"145","author":"E Hollander","year":"1988","unstructured":"Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR . Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings Am J Psychiatry 1988 145: 1015\u20131017","journal-title":"Am J Psychiatry"},{"key":"BF4001144_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1126\/science.273.5279.1225","volume":"273","author":"SS Wolf","year":"1996","unstructured":"Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding Science 1996 273: 1225\u20131227","journal-title":"Science"},{"key":"BF4001144_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/archpsyc.55.4.326","volume":"55","author":"BS Peterson","year":"1998","unstructured":"Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome Arch Gen Psychiatry 1998 55: 326\u2013333","journal-title":"Arch Gen Psychiatry"},{"key":"BF4001144_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0091-3057(96)00223-7","volume":"56","author":"K Matsumoto","year":"1997","unstructured":"Matsumoto K, Mizowaki M, Thongpraditchote S, Murakami Y, Watanabe H . alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice Pharmacol Biochem Behav 1997 56: 417\u2013422","journal-title":"Pharmacol Biochem Behav"},{"key":"BF4001144_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0014-2999(99)00184-3","volume":"371","author":"KM Campbell","year":"1999","unstructured":"Campbell KM, McGrath MJ, Burton FH . Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists Eur J Pharmacol 1999 371: 103\u2013111","journal-title":"Eur J Pharmacol"},{"key":"BF4001144_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1651-2227.1997.tb18357.x","volume":"422","author":"DJ Cohen","year":"1997","unstructured":"Cohen DJ, Leckman JF, Pauls D . Neuropsychiatric disorders of childhood: Tourette's syndrome as a model Acta Paediatr Suppl 1997 422: 106\u2013111","journal-title":"Acta Paediatr Suppl"},{"key":"BF4001144_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/ajp.154.11.1630-b","volume":"154","author":"SE Swedo","year":"1997","unstructured":"Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever Am J Psychiatry 1997 154: 110\u2013112","journal-title":"Am J Psychiatry"},{"key":"BF4001144_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0306-4530(92)90015-Y","volume":"17","author":"BS Peterson","year":"1992","unstructured":"Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ et al. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome Psychoneuroendocrinology 1992 17: 553\u2013563","journal-title":"Psychoneuroendocrinology"},{"key":"BF4001144_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/088307389601100205","volume":"11","author":"DG Lichter","year":"1996","unstructured":"Lichter DG, Jackson LA . Predictors of clonidine response in Tourette syndrome: implications and inferences J Child Neurol 1996 11: 93\u201397","journal-title":"J Child Neurol"},{"key":"BF4001144_CR37","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1097\/00001756-200007140-00053","volume":"11","author":"KM Campbell","year":"2000","unstructured":"Campbell KM, Veldman MB, McGrath MJ, Burton FH . TS+OCD-like neuropotentiated mice are supersensitive to seizure induction NeuroReport 2000 11: 2335\u20132338","journal-title":"NeuroReport"},{"key":"BF4001144_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0006-8993(00)02646-9","volume":"877","author":"MJ McGrath","year":"2000","unstructured":"McGrath MJ, Parks CRI, Burton FH . Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's Syndrome and obsessive-compulsive disorder Brain Res 2000 877: 23\u201330","journal-title":"Brain Res"},{"key":"BF4001144_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1469-7793.1999.00565.x","volume":"521","author":"SA Edgley","year":"1999","unstructured":"Edgley SA, Lemon RN . Experiments using transcranial magnetic brain stimulation in man could reveal important new mechanisms in motor control J Physiol (Lond) 1999 521: 565","journal-title":"J Physiol (Lond)"},{"key":"BF4001144_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00002826-199006000-00005","volume":"13","author":"MM Robertson","year":"1990","unstructured":"Robertson MM, Schnieden V, Lees AJ . Management of Gilles de la Tourette syndrome using sulpiride Clin Neuropharmacol 1990 13: 229\u2013235","journal-title":"Clin Neuropharmacol"},{"key":"BF4001144_CR41","first-page":"415","volume":"55","author":"A Ceccherini-Nelli","year":"1994","unstructured":"Ceccherini-Nelli A, Guazzelli M . Treatment of refractory OCD with the dopamine agonist bromocriptine J Clin Psychiatry 1994 55: 415\u2013416","journal-title":"J Clin Psychiatry"},{"key":"BF4001144_CR42","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","volume":"54","author":"DL Gilbert","year":"2000","unstructured":"Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR . Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial Neurology 2000 54: 1310\u20131315","journal-title":"Neurology"},{"key":"BF4001144_CR43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1176\/ajp.156.7.1122a","volume":"156","author":"C Bonnier","year":"1999","unstructured":"Bonnier C, Nassogne MC, Evrard P . Ketanserin treatment of Tourette's syndrome in children Am J Psychiatry 1999 156: 1122\u20131123","journal-title":"Am J Psychiatry"},{"key":"BF4001144_CR44","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1046\/j.1460-9568.1998.00250.x","volume":"10","author":"HC Cromwell","year":"1998","unstructured":"Cromwell HC, Berridge KC, Drago J, Levine MS . Action sequencing is impaired in D1A-deficient mutant mice Eur J Neurosci 1998 10: 2426\u20132432","journal-title":"Eur J Neurosci"},{"key":"BF4001144_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","volume":"36","author":"FX Castellanos","year":"1997","unstructured":"Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD et al. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose J Am Acad Child Adolesc Psychiatry 1997 36: 589\u2013596","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF4001144_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/104454601750284072","volume":"11","author":"CJ Kratochvil","year":"2001","unstructured":"Kratochvil CJ, Bohac D, Harrington M, Baker N, May D, Burke WJ . An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 2001 11: 167\u2013170","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BF4001144_CR47","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D Michelson","year":"2001","unstructured":"Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR et al. Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study Pediatrics 2001 108: E83","journal-title":"Pediatrics"},{"key":"BF4001144_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1034\/j.1600-0447.2000.102006401.x","volume":"102","author":"ML Carlsson","year":"2000","unstructured":"Carlsson ML . On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions Acta Psychiatr Scand 2000 102: 401\u2013413","journal-title":"Acta Psychiatr Scand"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4001144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4001144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T10:06:34Z","timestamp":1682330794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["BF4001144"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4001144","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]},"assertion":[{"value":"22 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2002","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2002","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2002","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}